Meta-Analysis
Copyright ©The Author(s) 2019.
World J Gastrointest Endosc. Mar 16, 2019; 11(3): 239-248
Published online Mar 16, 2019. doi: 10.4253/wjge.v11.i3.239
Table 1 Characteristics of the studies included in the endoscopic mucosal resection + radiofrequency ablation arms vs radiofrequency ablation alone
Ref.CountryCentersType of studySubjects (EMR + RFA/RFA aloneOutcomes
Li et al[10], 2015USA148Observational retrospective1263 (406/857)Efficacy and safety
Strauss et al[11], 2014USA2Observational retrospective36 (31/5)Efficacy and safety
Haidry et al[12], 2013England19Observational retrospective335 (164/171)Efficacy and safety
Kim et al[14], 2012USA1Observational retrospective169 (65/104)Efficacy and safety
Caillol et al[15], 2012France1Observational retrospective34 (16/18)Efficacy and safety
Okoro et al[16], 2012USA1Observational retrospective100 (44/46)Efficacy and safety
Pouw et al[17], 2008The Netherlands1Observational retrospective44 (31/13)Efficacy and safety

  • Citation: de Matos MV, da Ponte-Neto AM, de Moura DTH, Maahs ED, Chaves DM, Baba ER, Ide E, Sallum R, Bernardo WM, de Moura EGH. Treatment of high-grade dysplasia and intramucosal carcinoma using radiofrequency ablation or endoscopic mucosal resection + radiofrequency ablation: Meta-analysis and systematic review. World J Gastrointest Endosc 2019; 11(3): 239-248
  • URL: https://www.wjgnet.com/1948-5190/full/v11/i3/239.htm
  • DOI: https://dx.doi.org/10.4253/wjge.v11.i3.239